Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Protizinic acid inhibits phospholipase A2 (PLA2) with an IC 50 of 210 μM. Protizinic acid has antiinflammatory and antipyretic activity which is an orally active non-steroidal antiinflammatory agent [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Protizinic acid inhibits phospholipase A2 (PLA2) with an IC 50 of 210 μM. Protizinic acid has antiinflammatory and antipyretic activity which is an orally active non-steroidal antiinflammatory agent [1] [2]. |
In vitro | Protizinic acid both inhibits the in vitro production of leukokinin and acts antagonistically towards it at its receptor site [1]. |
In vivo | Utilizing an in vivo leukokinin (LK) generation system in a feline acute ischemia model, the administration of 3 mg/kg Protizinic acid via intravenous injection twice to cats experiencing acute cardiac ischemia inhibits increased blood acid protease activity and significantly prevents the reduction of leukokininogen, leukokinin's precursor [1]. Furthermore, the oral intake of 30 mg/kg Protizinic acid markedly reduces arachidonic acid-induced erythema in guinea pigs [2]. |
Molecular Weight | 315.39 |
Formula | C17H17NO3S |
CAS No. | 13799-03-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Protizinic acid 13799-03-6 inhibitor inhibit